Yinmin Gu

1.0k total citations
25 papers, 336 citations indexed

About

Yinmin Gu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yinmin Gu has authored 25 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Yinmin Gu's work include Cancer Immunotherapy and Biomarkers (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Yinmin Gu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Yinmin Gu collaborates with scholars based in China, United States and United Kingdom. Yinmin Gu's co-authors include Shan Gao, Tianyou Cheng, Qinong Ye, Dalong Song, Xiaohui Yang, Yongbo Pan, Yuhui Zhao, Yi Yuan, Xuetong Wang and Siyuan Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yinmin Gu

24 papers receiving 335 citations

Peers

Yinmin Gu

ONCOL

PRM

SURGE

Shaun Egolf United States

Xianju Qin China

Guobin Fu China

Xiaochuang Feng China

Binbin Cui China

Lihua Ding China

Weiyuan Wei China

Longci Sun China

Zhangwei Tong China

Shaun Egolf United States

Yinmin Gu

291 ×1.2

188 ×1.1

86 ×1.2

ONCOL

65 ×1.2

PRM

41 ×1.0

SURGE

Citations per year, relative to Yinmin Gu Yinmin Gu (= 1×) peers Shaun Egolf

Countries citing papers authored by Yinmin Gu

Since Specialization

Citations

This map shows the geographic impact of Yinmin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinmin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinmin Gu more than expected).

Fields of papers citing papers by Yinmin Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinmin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinmin Gu. The network helps show where Yinmin Gu may publish in the future.

Co-authorship network of co-authors of Yinmin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinmin Gu. A scholar is included among the top collaborators of Yinmin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinmin Gu. Yinmin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaodong, Xiaofeng Zhu, Liqiang Duan, et al.. (2025). PD-1^IR2 promotes tumor evasion via deregulating CD8⁺ T cell function. Journal for ImmunoTherapy of Cancer. 13(3). e010529–e010529. 2 indexed citations

Wang, Xiaodong, Xiaohui Yang, Yinmin Gu, et al.. (2025). Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis. Cancer Letters. 612. 217486–217486. 4 indexed citations

Zhang, Yibi, Xiaodong Wang, Yinmin Gu, et al.. (2025). Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells. Proceedings of the National Academy of Sciences. 122(4). e2420005122–e2420005122. 11 indexed citations

Peng, Bo, Yinmin Gu, Liqiang Duan, et al.. (2024). N-methyladenosine enhances the expression of TGF-β-SMAD signaling family to inhibit cell growth and promote cell metastasis. Cancer Letters. 603. 217195–217195. 7 indexed citations

Peng, Bo, Xiaofeng Zhu, Xuetong Wang, et al.. (2024). PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function. Cell Death and Disease. 15(11). 800–800. 12 indexed citations

Wang, Xuetong, Yifei Li, Chang Zhang, et al.. (2024). A splicing isoform of PD-1 promotes tumor progression as a potential immune checkpoint. Nature Communications. 15(1). 9114–9114. 9 indexed citations

Jiang, Siyuan, Yinmin Gu, Lihua Ding, et al.. (2023). HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1. Cell Death and Disease. 14(5). 327–327. 9 indexed citations

Jiang, Siyuan, et al.. (2023). Hypoxia inhibits HUNK kinase activity to induce epithelial-mesenchymal transition. Biochemical and Biophysical Research Communications. 681. 271–275.

Pan, Yongbo, Yinmin Gu, Qingqing Zhang, et al.. (2023). Epitranscriptic regulation of HRAS by N ⁶ -methyladenosine drives tumor progression. Proceedings of the National Academy of Sciences. 120(14). e2302291120–e2302291120. 13 indexed citations

10.

Fang, Pinhao, Xiaokun Li, Siyuan Luan, et al.. (2022). Prognostic Value of Geriatric Nutritional Risk Index in Esophageal Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Nutrition. 9. 831283–831283. 18 indexed citations

11.

Zhu, Yumeng, Yang Wang, Yongbo Pan, et al.. (2022). DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma. Cell Death and Disease. 13(5). 456–456. 19 indexed citations

12.

Jiang, Siyuan, Xuetong Wang, Dalong Song, et al.. (2019). Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP. Cancer Research. 79(12). 3063–3075. 81 indexed citations

13.

Gu, Yinmin, et al.. (2019). NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Yang, Xiaohui, Liang Wang, Rong Li, et al.. (2018). The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2. Biochemical and Biophysical Research Communications. 502(2). 262–268. 26 indexed citations

15.

Gu, Yinmin, Liang Wang, Yuhui Zhao, et al.. (2018). Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types. Journal of Cancer. 9(14). 2532–2542. 8 indexed citations

16.

Gu, Yinmin, et al.. (2017). Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion. Oncotarget. 8(20). 33745–33755. 2 indexed citations

17.

Gu, Yinmin, Yi Zou, Danqing Lei, et al.. (2017). Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma. Scientific Reports. 7(1). 14200–14200. 13 indexed citations

18.

Gu, Yinmin, Danqing Lei, Xia Qin, et al.. (2015). Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer. PLoS ONE. 10(10). e0140862–e0140862. 5 indexed citations

19.

Hu, Yanling, et al.. (2015). Integrated network model provides new insights into castration-resistant prostate cancer. Scientific Reports. 5(1). 17280–17280. 13 indexed citations

20.

Gu, Yinmin, et al.. (2014). Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk. Clinical & Translational Oncology. 16(10). 879–885. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact